Cytomegalovirus microRNA expression is tissue specific and is associated with persistence

Journal of Virology

Volumn 85, Issue 1, 2011, Pages 378-389

  Meyer, Christine ^a   Grey, Finn ^b   Kreklywich, Craig N ^a,c   Andoh, Takeshi F ^a,c   Tirabassi, Rebecca S ^d   Orloff, Susan L ^a,c   Streblow, Daniel N ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; GENE SEQUENCE; GENETIC VARIABILITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND DISEASE; TISSUE SPECIFICITY; VIRUS GENE; VIRUS GENOME;

ANIMALS; CELLS, CULTURED; FIBROBLASTS; HEART TRANSPLANTATION; HERPESVIRIDAE INFECTIONS; MICE; MICRORNAS; MUROMEGALOVIRUS; ORGAN SPECIFICITY; RATS; SALIVARY GLANDS; TRANSPLANTATION, HOMOLOGOUS;

CYTOMEGALOVIRUS; DNA VIRUSES; MAMMALIA; MURID HERPESVIRUS 2; RED CLOVER MOTTLE VIRUS;

EID: 78650065796     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01900-10     Document Type: Article

References (68)

1. Ameres, S. L., M. D. Horwich, J. H. Hung, J. Xu, M. Ghildiyal, Z. Weng, and P. D. Zamore. 2010. Target RNA-directed trimming and tailing of small silencing RNAs. Science 328:1534-1539.
2. Babiarz, J. E., J. G. Ruby, Y. Wang, D. P. Bartel, and R. Blelloch. 2008. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev. 22:2773-2785.
3. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Bartel, D. P., and C. Z. Chen. 2004. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5:396-400.
5. Beisser, P. S., C. Vink, J. G. Van Dam, G. Grauls, S. J. Vanherle, and C. A. Bruggeman. 1998. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J. Virol. 72:2352-2363.
6. Bruggeman, C. A., H. Schellekens, G. Grauls, W. M. Debie, and C. P. van Boven. 1983. Rat cytomegalovirus: induction of and sensitivity to interferon. Antiviral Res. 3:315-324.
7. Buck, A. H., J. Santoyo-Lopez, K. A. Robertson, D. S. Kumar, M. Reczko, and P. Ghazal. 2007. Discrete clusters of virus-encoded microRNAs are associated with complementary strands of the genome and the 7.2-kilobase stable intron in murine cytomegalovirus. J. Virol. 81:13761-13770.
8. Cai, X., and B. R. Cullen. 2006. Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs. J. Virol. 80:2234-2242.
9. Cai, X., A. Schäfer, S. Lu, J. P. Bilello, R. C. Desrosiers, R. Edwards, N. Raab-Traub, and B. R. Cullen. 2006. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2:e23.
10. Chiang, H. R., L. W. Schoenfeld, J. G. Ruby, V. C. Auyeung, N. Spies, D. Baek, W. K. Johnston, C. Russ, S. Luo, J. E. Babiarz, R. Blelloch, G. P. Schroth, C. Nusbaum, and D. P. Bartel. 2010. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev. 24:992-1009.
11. Choy, E. Y., K. L. Siu, K. H. Kok, R. W. Lung, C. M. Tsang, K. F. To, D. L. Kwong, S. W. Tsao, and D. Y. Jin. 2008. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 205:2551-2560.
12. Cosmopoulos, K., M. Pegtel, J. Hawkins, H. Moffett, C. Novina, J. Middeldorp, and D. A. Thorley-Lawson. 2009. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 83:2357-2367.
13. Courcelle, C. T., J. Courcelle, M. N. Prichard, and E. S. Mocarski. 2001. Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J. Virol. 75:7592-7601.
14. de Otero, J., J. Gavalda, E. Murio, et al. 1998. Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation. Clin. Infect. Dis. 26:865-870.
15. Dölken, L., J. Perot, V. Cognat, A. Alioua, M. John, J. Soutschek, Z. Ruzsics, U. Koszinowski, O. Voinnet, and S. Pfeffer. 2007. Mouse cytomegalovirus micro-RNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J. Virol. 81:13771-13782.
16. Dunn, W., P. Trang, Q. Zhong, E. Yang, C. van Belle, and F. Liu. 2005. Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell. Microbiol. 7:1684-1695.
17. Ebhardt, H. A., A. Fedynak, and R. P. Fahlman. 2010. Naturally occurring variations in sequence length creates microRNA isoforms that differ in Argonaute effector complex specificity. Silence 1:12.
18. Ebhardt, H. A., H. H. Tsang, D. C. Dai, Y. Liu, B. Bostan, and R. P. Fahlman. 2009. Meta-analysis of small RNA-sequencing errors reveals ubiquitous post-transcriptional RNA modifications. Nucleic Acids Res. 37:2461-2470.
19. Ghildiyal, M., J. Xu, H. Seitz, Z. Weng, and P. D. Zamore. 2010. Sorting of Drosophila small silencing RNAs partitions microRNA* strands into the RNA interference pathway. RNA 16:43-56.
20. Grattan, M. T., C. E. Moreno-Cabral, V. A. Starnes, P. E. Oyer, E. B. Stinson, and N. E. Shumway. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566.
21. Grey, F., A. Antoniewicz, E. Allen, J. Saugstad, A. McShea, J. C. Carrington, and J. Nelson. 2005. Identification and characterization of human cytomegalovirus-encoded microRNAs. J. Virol. 79:12095-12099. (Pubitemid 41279327)
22. Grey, F., L. Hook, and J. Nelson. 2008. The functions of herpesvirus-encoded microRNAs. Med. Microbiol. Immunol. 197:261-267.
23. Grey, F., H. Meyers, E. A. White, D. H. Spector, and J. Nelson. 2007. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog. 3:e163.
24. Grey, F., R. Tirabassi, H. Meyers, G. Wu, S. McWeeney, L. Hook, and J. A. Nelson. 2010. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5′UTRs. PLoS Pathog. 6:e1000967.
25. Grundhoff, A., C. S. Sullivan, and D. Ganem. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12:733-750.
26. Handa, N., M. Hatanaka, W. A. Baumgartner, B. A. Reitz, G. Sandford, A. H. Esa, and A. Herskowitz. 1993. Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts. Transplantation 56:535-540.
27. Hillebrands, J. L., J. G. van Dam, G. Onuta, F. A. Klatter, G. Grauls, C. A. Bruggeman, and J. Rozing. 2005. Cytomegalovirus-enhanced development of transplant arteriosclerosis in the rat; effect of timing of infection and recipient responsiveness. Transpl. Int. 18:735-742.
28. Kloover, J. S., J. L. Hillebrands, G. de Wit, G. Grauls, J. Rozing, C. A. Bruggeman, and P. Nieuwenhuis. 2000. Rat cytomegalovirus replication in the salivary glands is exclusively confined to striated duct cells. Virchows Arch. 437:413-421.
29. Kloppenburg, G., R. de Graaf, S. Herngreen, G. Grauls, C. Bruggeman, and F. Stassen. 2005. Cytomegalovirus aggravates intimal hyperplasia in rats by stimulating smooth muscle cell proliferation. Microbes Infect. 7:164-170.
30. Koskinen, P., K. Lemström, S. Mattila, P. Hayry, and M. S. Nieminen. 1996. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft. Clin. Transplant. 10:487-493.
31. Koskinen, P. K., S. Yilmaz, E. Kallio, C. A. Bruggeman, P. J. Hayry, and K. Lemström. 1996. Rat cytomegalovirus infection and chronic kidney allograft rejection. Transpl. Int. 9:S3-S4.
32. Kuchenbauer, F., R. D. Morin, B. Argiropoulos, O. I. Petriv, M. Griffith, M. Heuser, E. Yung, J. Piper, A. Delaney, A. L. Prabhu, Y. Zhao, H. McDonald, T. Zeng, M. Hirst, C. L. Hansen, M. A. Marra, and R. K. Humphries. 2008. In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Res. 18:1787-1797.
33. Lagana, A., S. Forte, F. Russo, R. Giugno, A. Pulvirenti, and A. Ferro. 2010. Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints. J. RNAi Gene Silencing 6:379-385.
34. Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A. O. Kamphorst, M. Landthaler, C. Lin, N. D. Socci, L. Hermida, V. Fulci, S. Chiaretti, R. Foa, J. Schliwka, U. Fuchs, A. Novosel, R. U. Muller, B. Schermer, U. Bissels, J. Inman, Q. Phan, M. Chien, D. B. Weir, R. Choksi, G. De Vita, D. Frezzetti, H. I. Trompeter, V. Hornung, G. Teng, G. Hartmann, M. Palkovits, R. Di Lauro, P. Wernet, G. Macino, C. E. Rogler, J. W. Nagle, J. Ju, F. N. Papavasiliou, T. Benzing, P. Lichter, W. Tam, M. J. Brownstein, A. Bosio, A. Borkhardt, J. J. Russo, C. Sander, M. Zavolan, and T. Tuschl. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414.
35. Lee, R. C., R. L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.
36. Lemström, K. B., P. T. Aho, C. A. Bruggeman, and P. J. Hayry. 1994. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta I in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler. Thromb. 14:2043-2052.
37. Lemström, K. B., J. H. Bruning, C. A. Bruggeman, P. Koskinen, P. T. Aho, S. Yilmaz, I. T. Lautenschlager, and P. J. Hayry. 1994. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation 90:1969-1978.
38. Lemström, K. B., P. K. Koskinen, J. H. Bruning, C. A. Bruggeman, I. T. Lautenschlager, and P. J. Hayry. 1994. Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis. Transpl. Int. 7(Suppl. 1):S383-S384.
39. Martelius, T., M. Scholz, L. Krogerus, K. Hockerstedt, R. Loginov, C. Bruggeman, J. Cinatl, Jr., H. W. Doerr, and I. Lautenschlager. 1999. Antiviral and immunomodulatory effects of desferrioxamine in cytomegalovirusinfected rat liver allografts with rejection. Transplantation 68:1753-1761.
40. Melnick, J. L., E. Adam, and M. E. DeBakey. 1998. The link between CMV and atherosclerosis. Infect. Med. 15:479-486.
41. Melnick, J. L., B. L. Petrie, G. R. Dreesman, J. Burek, C. H. McCollum, and M. E. DeBakey. 1983. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2(8351):644-647.
42. Melnychuk, R. M., D. N. Streblow, P. P. Smith, A. J. Hirsch, D. Pancheva, and J. A. Nelson. 2004. Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J. Virol. 78:8382-8391.
43. Murphy, E., J. Vanicek, H. Robins, T. Shenk, and A. J. Levine. 2008. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc. Natl. Acad. Sci. U. S. A. 105:5453-5458.
44. Norseen, J., A. Thomae, V. Sridharan, A. Aiyar, A. Schepers, and P. M. Lieberman. 2008. RNA-dependent recruitment of the origin recognition complex. EMBO J. 27:3024-3035.
45. Orloff, S. L., D. N. Streblow, C. Soderberg-Naucler, Q. Yin, C. Kreklywich, C. L. Corless, P. A. Smith, C. B. Loomis, L. K. Mills, J. W. Cook, C. A. Bruggeman, J. A. Nelson, and C. R. Wagner. 2002. Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. Transplantation 73:679-688.
46. Persoons, M. C. J., M. J. A. P. Daemen, E. M. van Kleef, G. E. L. M. Grauls, E. Wijers, and C. A. Bruggeman. 1997. Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. Cardiovasc. Res. 36:282-288.
47. Pfeffer, S., A. Sewer, M. Lagos-Quintana, R. Sheridan, C. Sander, F. A. Grasser, L. F. van Dyk, C. K. Ho, S. Shuman, M. Chien, J. J. Russo, J. Ju, G. Randall, B. D. Lindenbach, C. M. Rice, V. Simon, D. D. Ho, M. Zavolan, and T. Tuschl. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods 2:269-276.
48. Pfeffer, S., M. Zavolan, F. A. Grasser, M. Chien, J. J. Russo, J. Ju, B. John, A. J. Enright, D. Marks, C. Sander, and T. Tuschl. 2004. Identification of virus-encoded microRNAs. Science 304:734-736.
49. Pratt, Z. L., M. Kuzembayeva, S. Sengupta, and B. Sugden. 2009. The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology 386:387-397.
50. Ramkissoon, S. H., L. A. Mainwaring, Y. Ogasawara, K. Keyvanfar, J. P. McCoy, Jr., E. M. Sloand, S. Kajigaya, and N. S. Young. 2006. Hematopoietic-specific microRNA expression in human cells. Leuk. Res. 30:643-647.
51. Rana, T. M. 2007. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8:23-36.
52. Rubin, R. H. 1999. Importance of CMV in the transplant population. Transpl. Infect. Dis. 1(Suppl. 1):3-7.
53. Samols, M. A., J. Hu, R. L. Skalsky, and R. Renne. 2005. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:9301-9305.
54. Schäfer, A., X. Cai, J. P. Bilello, R. C. Desrosiers, and B. R. Cullen. 2007. Cloning and analysis of microRNAs encoded by the primate gamma-herpesvirus rhesus monkey rhadinovirus. Virology 364:21-27.
55. Skalsky, R. L., and B. R. Cullen. 2010. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64:123-141.
56. Soule, J. L., D. N. Streblow, T. F. Andoh, C. N. Kreklywich, and S. L. Orloff. 2006. Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles. Transplant. Proc. 38:3214-3220.
57. Speir, E., R. Modali, E. S. Huang, M. B. Leon, F. Shawl, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
58. Steinhoff, G., X. M. You, C. Steinmuller, K. Boeke, F. S. Stals, C. A. Bruggeman, and A. Haverich. 1995. Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat. Scand. J. Infect. Dis. Suppl. 99:58-60.
59. Stern-Ginossar, N., N. Elefant, A. Zimmermann, D. G. Wolf, N. Saleh, M. Biton, E. Horwitz, Z. Prokocimer, M. Prichard, G. Hahn, D. Goldman-Wohl, C. Greenfield, S. Yagel, H. Hengel, Y. Altuvia, H. Margalit, and O. Mandelboim. 2007. Host immune system gene targeting by a viral miRNA. Science 317:376-381.
60. Stern-Ginossar, N., N. Saleh, M. D. Goldberg, M. Prichard, D. G. Wolf, and O. Mandelboim. 2009. Analysis of human cytomegalovirus-encoded microRNA activity during infection. J. Virol. 83:10684-10693.
61. Streblow, D. N., J. Dumortier, A. V. Moses, S. L. Orloff, and J. A. Nelson. 2008. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr. Top. Microbiol. Immunol. 325:397-415.
62. Streblow, D. N., C. Kreklywich, Q. Yin, V. T. De La Melena, C. L. Corless, P. A. Smith, C. Brakebill, J. W. Cook, C. Vink, C. A. Bruggeman, J. A. Nelson, and S. L. Orloff. 2003. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J. Virol. 77:2182-2194.
63. Streblow, D. N., C. N. Kreklywich, T. Andoh, A. V. Moses, J. Dumortier, P. P. Smith, V. Defilippis, K. Fruh, J. A. Nelson, and S. L. Orloff. 2008. The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am. J. Transplant. 8:277-287.
64. Streblow, D. N., C. N. Kreklywich, P. Smith, J. L. Soule, C. Meyer, M. Yin, P. Beisser, C. Vink, J. A. Nelson, and S. L. Orloff. 2005. Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am. J. Transplant. 5:436-442.
65. Streblow, D. N., K. W. van Cleef, C. N. Kreklywich, C. Meyer, P. Smith, V. Defilippis, F. Grey, K. Fruh, R. Searles, C. Bruggeman, C. Vink, J. A. Nelson, and S. L. Orloff. 2007. Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro. J. Virol. 81:3816-3826.
66. Xia, T., A. O'Hara, I. Araujo, J. Barreto, E. Carvalho, J. B. Sapucaia, J. C. Ramos, E. Luz, C. Pedroso, M. Manrique, N. L. Toomey, C. Brites, D. P. Dittmer, and W. J. Harrington, Jr. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 68:1436-1442.
67. Ziegelbauer, J. M., C. S. Sullivan, and D. Ganem. 2009. Tandem array-based expression screens identify host mRNA targets of virus-encoded micro-RNAs. Nat. Genet. 41:130-134.
68. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415. (Pubitemid 37442169)